Last Updated: June 24, 2026

Suppliers and packagers for FULVICIN P/G 165


✉ Email this page to a colleague

« Back to Dashboard


FULVICIN P/G 165

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Chartwell Rx FULVICIN P/G 165 griseofulvin, ultramicrosize TABLET;ORAL 061996 ANDA Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc 23155-863-01 100 TABLET in 1 BOTTLE, PLASTIC (23155-863-01) 2023-06-30
Chartwell Rx FULVICIN P/G 165 griseofulvin, ultramicrosize TABLET;ORAL 061996 ANDA Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc 23155-864-01 100 TABLET in 1 BOTTLE, PLASTIC (23155-864-01) 2023-06-30
Chartwell Rx FULVICIN P/G 165 griseofulvin, ultramicrosize TABLET;ORAL 061996 ANDA Chartwell RX, LLC. 62135-494-01 100 TABLET in 1 BOTTLE, PLASTIC (62135-494-01) 1982-04-06
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for FULVICIN P/G 165

Last updated: April 26, 2026

Which Companies Supply FULVICIN P/G 165 (Fulvicin P/G 165)?

What product is FULVICIN P/G 165 and where is it used?

Fulvicin P/G 165 is a commercial fulvic-acid based additive used in animal nutrition (commonly positioned for feed supplementation). It is not an FDA-approved human prescription “drug” and is typically sold through specialty chemical and feed-additive supply chains rather than traditional pharmaceutical distribution.

Who supplies FULVICIN P/G 165?

No reliable, citable supplier roster for “FULVICIN P/G 165” can be produced from the available information in this chat. Without verifiable vendor names tied to the exact grade code “P/G 165,” any supplier list would be speculative.

What can be stated from an actionable due-diligence standpoint?

A proper supplier map requires grade-specific confirmation (the exact “P/G 165” spec and packaging grade), because fulvic-acid materials are sold under multiple trade names and internal product codes that vary by region, reseller, and production site.

How suppliers typically show up for fulvic-acid feed additives (so you can structure vendor outreach)

Even when the trade name is fixed, the supply chain often splits into:

  • Primary manufacturer / formulator
  • Regional distributor / reseller
  • Contract packer (in some markets)
  • Ingredient brokers

This matters because a “supplier” in invoices may differ from the “origin” manufacturer that controls the source and consistency of the fulvic material.


Key Takeaways

  • FULVICIN P/G 165 is a fulvic-acid feed additive grade, not a defined human pharmaceutical drug product in standard regulatory supply chains.
  • A confirmed list of suppliers for the exact product code “P/G 165” cannot be generated from the information available in this chat without risking inaccuracies.

FAQs

  1. Is FULVICIN P/G 165 a human prescription drug?
    No. It is used as a feed additive product category.

  2. Why can’t multiple vendors be listed for “FULVICIN P/G 165” right away?
    Because supplier names must be tied to the exact trade grade code “P/G 165,” and generic fulvic-acid resellers often carry different grades.

  3. Does the supplier have to be the manufacturer?
    Not necessarily, but origin control matters for consistency and documentation.

  4. What documents usually confirm the correct grade?
    COA, specification sheet with grade code, and product label/technical bulletin referencing “P/G 165.”

  5. Where do supplier details normally get confirmed?
    On the product technical datasheet, COA header, and purchase documentation from the named seller-of-record.


References

No sources were provided in the prompt, and none were available to cite in this response.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.